X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
https://www.fda.gov/safety/medical-product-safety-information/belviq-belviq-xr-lorcaserin-eisai-drug-safety-communication-fda-requests-withdrawal-weight-loss-drug
https://www.fiercepharma.com/pharma/eisai-will-pull-belviq-off-u-s-shelves-after-trial-shows-increased-cancer-risk
https://www.raps.org/news-and-articles/news-articles/2020/1/fda-warns-of-potential-cancer-risk-with-weight-los
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209464
https://endpts.com/united-therapeutics-pays-800m-plus-to-grab-arenas-phiii-pah-drug/
https://www.biospectrumasia.com/news/25/11893/eisai-signs-pact-with-eurofarma-for-anti-obesity-agent-.html
https://www.rdmag.com/news/2018/08/weight-loss-drug-does-not-increase-cardiovascular-events
https://endpts.com/a-new-avenue-for-diet-pill-makers-uc-san-diego-researchers-uncover-root-of-leptin-resistance/
https://www.fiercepharma.com/marketing/eisai-obesity-drug-belviq-picks-up-edge-long-awaited-heart-safety-data
https://endpts.com/with-debt-looming-browbeaten-diet-pill-maker-orexigen-goes-bankrupt/
http://www.fiercepharma.com/pharma/eisai-s-lenvima-moves-toward-nexavar-showdown-phase-3-liver-cancer-win
http://www.prnewswire.com/news-releases/eisai-acquires-all-global-development-and-marketing-rights-for-chronic-weight-management-treatment-lorcaserin-hci-300385785.html
http://www.biospace.com/News/socal-biotech-arena-officially-bails-on-weight/443285/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
https://www.statnews.com/pharmalot/2016/10/28/arena-pharmaceutical-shareholder-suit/
http://www.prnewswire.com/news-releases/eisais-lenvima-lenvatinib-nominated-for-galien-foundations-best-pharmaceutical-product-300351860.html
https://www.pharmacompass.com/pdf/news/eisai-inc-arena-announce-fda-approval-of-belviq-xr-lorcaserin-hcl-1469095205.pdf
http://www.prnewswire.com/news-releases/eisai-and-arena-pharmaceuticals-announce-regulatory-approval-of-venespri-lorcaserin-hcl-in-mexico-300298531.html
http://www.reuters.com/article/us-orexigen-deals-idUSKCN0WH1DB
http://cphi-online.com/future-obesity-drugs-must-provide-improved-news038407.html
http://www.fiercepharma.com/story/struggling-eisai-looks-help-china-new-generics-deal/2015-12-03
http://www.prnewswire.com/news-releases/eisai-and-arena-pharmaceuticals-announce-completion-of-enrollment-in-belviq-lorcaserin-hci-camellia-timi-61-study-300185958.html
http://247wallst.com/healthcare-business/2015/11/30/arena-pharma-soars-on-fda-approval/?
http://www.prnewswire.com/news-releases/eisai-and-arena-pharmaceuticals-announce-fda-acceptance-of-new-drug-application-for-extended-release-formulation-of-lorcaserin-300185100.html
http://www.fiercepharmamarketing.com/story/are-takedas-900-contrave-reps-worth-it-maybe-not-analyst-says/2015-11-09
http://www.prnewswire.com/news-releases/arena-pharmaceuticals-issued-additional-patent-covering-belviq-lorcaserin-hcl-by-united-states-patent-and-trademark-office-300166484.html
http://www.fiercepharma.com/story/investors-cheer-arena-forces-out-ceo-and-cofounder/2015-10-06
http://www.pmlive.com/pharma_news/eisai_launches_thyroid_cancer_therapy_lenvima_in_uk_754243
http://www.fiercepharmamarketing.com/story/brutal-honesty-drug-marketing-obesity-meds-its-key-avoiding-magic-pill-trap/2015-06-08
http://www.fiercepharma.com/story/eisai-shed-450-jobs-it-pares-down-us-workforce-one-fourth/2015-04-09
http://blogs.wsj.com/pharmalot/2015/04/02/vivus-goes-on-a-diet-sales-reps-are-cut-but-will-fda-help-save-money/
http://www.fiercepharma.com/story/eisai-gets-ema-nod-lenvima-just-weeks-after-fda-approval/2015-03-27
http://www.medpagetoday.com/Endocrinology/Diabetes/50672?xid=nl_mpt_DHE_2015-03-27&eun=g655567d0r&userid=655567&mu_id=5789356
http://www.fiercepharmamarketing.com/story/surprise-obesity-med-contrave-might-help-cv-outcomes-too-bad-orexigen-blabb/2015-03-04
http://www.fiercebiotech.com/story/eisai-says-its-new-thyroid-cancer-drug-sure-blockbuster/2015-02-12
http://pharmaceuticals.einnews.com/pr_news/241017082/b-lipo-capsules-by-bethel-nutritional-consulting-inc-recall-undeclared-drug-ingredient
Market Place
Share 
